Skip to main content
Top

Current Treatment Options in Oncology

Issue 12/2023

Content (19 Articles)

Open Access Ovarian Cancer

Frontiers of Ovarian Carcinosarcoma

Ayden Ismail, Sunyoung Choi, Stergios Boussios

Open Access Crizotinib

Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor

Qi-An Wang, Huan-Wu Chen, Ren-Chin Wu, Chiao-En Wu

Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer

Oluwadunni E. Emiloju, Mojun Zhu, Hao Xie, Zhaohui Jin, Frank A. Sinicrope, Joleen M. Hubbard

Open Access Vandetanib

The Evolving Treatment Landscape of Medullary Thyroid Cancer

Marta Laganà, Valentina Cremaschi, Andrea Alberti, Danica M. Vodopivec Kuri, Deborah Cosentini, Alfredo Berruti

The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective

Laura Mariën, Odeta Islam, Siddharth Chhajlani, Willem Lybaert, Marc Peeters, Guy Van Camp, Ken Op de Beeck, Timon Vandamme

Open Access Kidney Cancer

Treatment Landscape of Renal Cell Carcinoma

Yu-Wei Chen, Luke Wang, Justine Panian, Sohail Dhanji, Ithaar Derweesh, Brent Rose, Aditya Bagrodia, Rana R. McKay

Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer

Yinan Yu, Jianguo Zhao, Jiaona Xu, Rui Bai, Zewei Gu, Xialin Chen, Jianfang Wang, Xueying Jin, Gaoyang Gu

Systemic Therapy for Melanoma Brain and Leptomeningeal Metastases

Wendy J. Sherman, Edoardo Romiti, Loizos Michaelides, Diogo Moniz-Garcia, Kaisorn L. Chaichana, Alfredo Quiñones-Hinojosa, Alyx B. Porter

Non-Surgical Therapeutic Strategies for Non-Melanoma Skin Cancers

Qingyu Zeng, Chengqian Chen, Diyan Chen, Guolong Zhang, Xiuli Wang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine